Journal of Diabetes·Mar 7Sodium-Glucose Cotransporter 2 Inhibitors for Metabolic Dysfunction-Associated SteatohepatitisTrial in peopleSGLT2 inhibitorsPaper
Liver International·Feb 14Liver-Pancreas Fat Deposition: Impact on Cardiometabolic Multimorbidity and Cardiac DysfunctionCohort study of 16,408 peopleCardiac dysfunctionPaper
Human Pathology·Nov 24Impact of gender and age on the histologic severity of metabolic syndrome associated steatohepatitisCohort study of 407 peopleLipid and ceramide metabolismPaper
The Journal of Clinical Endocrinology and Metabolism·Sep 16Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysisMeta-analysis of randomized trialsMetabolic dysfunction-associated steatohepatitisPaper
Biomolecules·Aug 30Targeting HMGCS2: Ketogenesis Suppression Accelerates NAFLD Progression in T2DM Comorbidity, While Cynaroside Ameliorates NASH in Concomitant T2DMExperiments in miceInterventionsPaper
The Journal of Clinical Endocrinology and Metabolism·Dec 21A Population-Based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic HyperferritinemiaCohort study in peopleBiomarkersPaper
Free Radical Biology & Medicine·Nov 28Pharmacological and genetic increases in liver NADPH levels ameliorate NASH progression in female miceExperiments in miceInterventionsPaper
Sleep & Breathing·Jul 16Intermittent hypoxia induces hepatic senescence through promoting oxidative stress in a mouse modelExperiments in miceOxidative stress and ROS signalingPaper
JBMR Plus·Dec 20Are Nonalcoholic Fatty Liver Disease and Bone Mineral Density Associated? - A Cross-Sectional Study Using Liver Biopsy and Dual-Energy X-Ray AbsorptiometryStudy in peoplePopulationsPaper
Medical Science Monitor·Sep 12Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)CommentaryGLP-1 receptor agonistsPaper
Hepatology·May 1Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD PhenotypesExperiments in miceMechanismsPaper
Journal of Translational Internal Medicine·Oct 23Effect of Weight Reduction on Histological Activity and Fibrosis of Lean Nonalcoholic Steatohepatitis PatientNon-randomized trial in peopleMetabolic dysfunction-associated steatohepatitisPaper
Life Sciences·Jan 11A maternal high-fat diet may accelerate adipo-immunologic aging in offspringExperiments in animalsInterventionsPaper